TWAV:NASDAQTaoWeave, Inc. Analysis
Data as of 2026-06-12 - not real-time
$1.74
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical snapshot shows the stock trading below its 20‑day moving average while remaining above the 200‑day average, with the 14‑day RSI sitting in a neutral zone and the MACD line emitting a bullish signal. Price action has been volatile – after‑hours the share slipped sharply following the Q1 release, reflecting market skepticism despite a reported net income boost from unrealized TAO gains.
The fundamentals paint a stark picture: revenue is modest, margins are deeply negative, cash flow is strongly negative, and the balance sheet is clean with no debt but also no earnings power. The price‑to‑book ratio below one signals that the market price is materially lower than book value, hinting at an undervalued stance from a pure value perspective.
Risk factors are pronounced – beta and volatility are high, the sector is a niche crypto‑focused financial service with regulatory uncertainty, and liquidity is thin given the small market cap and rising volume trend. The sentiment gauge sits in the “Extreme Greed” band, which together with a bearish trend direction amplifies downside risk in the near term.
The fundamentals paint a stark picture: revenue is modest, margins are deeply negative, cash flow is strongly negative, and the balance sheet is clean with no debt but also no earnings power. The price‑to‑book ratio below one signals that the market price is materially lower than book value, hinting at an undervalued stance from a pure value perspective.
Risk factors are pronounced – beta and volatility are high, the sector is a niche crypto‑focused financial service with regulatory uncertainty, and liquidity is thin given the small market cap and rising volume trend. The sentiment gauge sits in the “Extreme Greed” band, which together with a bearish trend direction amplifies downside risk in the near term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- post‑earnings price decline
- bearish technical indicators
- weak operating margins
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- unrealized TAO gains
- extreme greed sentiment
- high beta may amplify future moves
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- long‑term AI ecosystem exposure
- valuation indicates price below book value
- ongoing cash burn without clear path to profitability
Key Metrics & Analysis
Financial Health
Revenue Growth13.70%
Profit Margin-158.05%
ROE-66.02%
ROA-24.01%
P/B Ratio0.8
Op. Cash Flow$-2985000
Free Cash Flow$-9079750
Industry P/E16.6
Technical Analysis
TrendBearish
RSI57.7
Support$1.13
Resistance$2.58
MA 20$1.53
MA 50$1.64
MA 200$1.96
MACDBullish
VolumeIncreasing
Fear & Greed Index87.73
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.89
Volatility101.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.